94 related articles for article (PubMed ID: 1725573)
1. Urinary kallikrein excretion in chronic pancreatic diseases.
Fabris C; Panozzo MP; Basso D; Del Favero G; Plebani M; Zaninotto M; Fogar P; Meggiato T; Scalon P; Ferrara C
Am J Nephrol; 1991; 11(5):386-90. PubMed ID: 1725573
[TBL] [Abstract][Full Text] [Related]
2. Renal tubular dysfunction in pancreatic cancer and chronic pancreatitis.
Fabris C; Basso D; Del Favero G; Piccoli A; Angonese C; Di Mario F; Plebani M; Bonvicini P; Burlina A; Naccarato R
Nephron; 1989; 51(1):56-60. PubMed ID: 2563574
[TBL] [Abstract][Full Text] [Related]
3. Renal handling of amylase and immunoreactive trypsin in pancreatic cancer and chronic pancreatitis.
Fabris C; Basso D; Del Favero G; Meggiato T; Piccoli A; Angonese C; Plebani M; Bonvicini P; Brulina A; Naccarato R
Clin Physiol Biochem; 1990; 8(1):30-7. PubMed ID: 1691065
[TBL] [Abstract][Full Text] [Related]
4. Urinary elastase 1 in chronic pancreatic disease.
Fabris C; Basso D; Benini L; Meggiato T; Del Favero G; Cavallini G; Panozzo MP; Fogar P; Angonese C; Vantini I
Enzyme; 1989; 42(2):80-6. PubMed ID: 2591350
[TBL] [Abstract][Full Text] [Related]
5. Renal involvement in chronic pancreatic disease: effects on trypsin and amylase plasma-urine transfer.
Fabris C; Basso D; Del Favero G; Benini L; Angonese C; Piccoli A; Plebani M; Burlina A; Naccarato R
Int J Pancreatol; 1988; 3 Suppl 1():S59-65. PubMed ID: 2463319
[TBL] [Abstract][Full Text] [Related]
6. The hourly rate of urinary amylase excretion, serum amylase, and serum lipase. II. Patients with gastrointestinal and pancreatic disorders.
Waller SL; Ralston AJ
Gut; 1971 Nov; 12(11):884-90. PubMed ID: 5132218
[TBL] [Abstract][Full Text] [Related]
7. Urinary phospholipase A2 excretion in chronic pancreatic diseases.
Fabris C; Basso D; Panozzo MP; Del Favero G; Meggiato T; Plebani M; Ferrara C; Fogar P; Zaninotto M; Naccarato R
Int J Pancreatol; 1992 Jun; 11(3):179-84. PubMed ID: 1517657
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship?
Basso D; Panozzo MP; Plebani M; Meggiato T; Zaninotto M; Piccoli A; Fogar P; Ferrara C; Del Favero G; Burlina A
J Med; 1994; 25(1-2):91-104. PubMed ID: 7930960
[TBL] [Abstract][Full Text] [Related]
9. Fractional urinary clearance of immunoreactive lipase in chronic pancreatic disease.
Benini L; Rizzotti P; Vaona B; Vantini I; Sembenini C; Marini M; Brocco G; Cavallini G; Scuro LA
J Clin Chem Clin Biochem; 1988 Aug; 26(8):527-9. PubMed ID: 3065442
[TBL] [Abstract][Full Text] [Related]
10. Does renal tubular dysfunction account for the enhanced CAm/CCr ratio in acute pancreatitis?
Bergia R; Andriulli A; Masoero G; Baiardi P; Pellegrino S; Tondolo M
Gastroenterology; 1980 May; 78(5 Pt 1):986-90. PubMed ID: 6155308
[TBL] [Abstract][Full Text] [Related]
11. Renal factors in serum trypsinogen 1 metabolism and excretion in chronic pancreatic disease.
Fabris C; Benini L; Basso D; Del Favero G; Vantini I; Piccoli A; Cavallini G; Scuro LA; Naccarato R
Pancreas; 1988; 3(1):25-9. PubMed ID: 3362841
[TBL] [Abstract][Full Text] [Related]
12. Urinary ribonuclease excretion in pancreatic disease.
Fabris C; Meani A; Farini R; Vianello D; del Favero G; Piccoli A; Bonvicini P; Brosolo P; Naccarato R
J Clin Chem Clin Biochem; 1983 Sep; 21(9):573-5. PubMed ID: 6631338
[TBL] [Abstract][Full Text] [Related]
13. The twenty-four hour excretion of amylase and lipase in the urine: correlation with the functional state and operative injury of the pancreas.
Ambromovage AM; Howard JM; Pairent FW
Ann Surg; 1968 Apr; 167(4):539-46. PubMed ID: 5644728
[No Abstract] [Full Text] [Related]
14. Urinary kallikrein excretion in idiopathic nephrotic syndrome.
Brouhard BH; Cunningham RJ; Petrusick TW; Berger M; Travis LB
J Urol; 1979 May; 121(5):672-4. PubMed ID: 439267
[TBL] [Abstract][Full Text] [Related]
15. Urinary enzymes excretion in pancreatic diseases. Clinical role and pathophysiological considerations.
Fabris C; Basso D; Naccarato R
J Clin Gastroenterol; 1992 Jun; 14(4):281-4. PubMed ID: 1376738
[TBL] [Abstract][Full Text] [Related]
16. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
[TBL] [Abstract][Full Text] [Related]
17. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control.
Mayfield RK; Margolius HS; Levine JH; Wohltmann HJ; Loadholt CB; Colwell JA
J Clin Endocrinol Metab; 1984 Aug; 59(2):278-86. PubMed ID: 6564131
[TBL] [Abstract][Full Text] [Related]
18. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
19. Urinary kallikrein response to acute saline or water loads in hypertensive and normal humans.
Lawton WJ
Hypertension; 1984; 6(2 Pt 1):175-83. PubMed ID: 6563013
[TBL] [Abstract][Full Text] [Related]
20. Diurnal variation in water, sodium and potassium excretion in primary glomerulonephritic patients and its relation to diurnal kallikrein excretion.
Chen YM; Tsai TJ; Chang PI; Hsieh BS; Chen WY; Yen TS
J Formos Med Assoc; 1990 Dec; 89(12):1052-6. PubMed ID: 1982672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]